Editorial introductions : Current Opinion in Organ Transplantation

Secondary Logo

Journal Logo


Editorial introductions

Editor(s): Sher, Linda S.; Grinyó, Josep M.; Kupiec-Weglinski, Jerzy; Mandelbrot, Didier

Current Opinion in Organ Transplantation 28(1):p vi, February 2023. | DOI: 10.1097/MOT.0000000000001043
  • Free

Current Opinion in Organ Transplantation was launched in 1996. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of organ transplantation is divided into 18 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Editors-in-Chief, Associate Editor and Section Editors for this issue.


Linda S. Sher

Linda S. Sher

Dr Linda S. Sher is Professor of Clinical Surgery and Director of Clinical Research in the Division of Hepatobiliary Surgery and Abdominal Organ Transplantation at Keck School of Medicine, University of Southern California (USC), USA. After completing her medical school education and surgical residency at Mount Sinai School of Medicine in New York, USA, Dr Sher undertook her fellowship training in Liver and Kidney Transplantation at the University of Pittsburgh, USA. After completing her fellowship in 1988, Dr Sher was involved in the establishment of two liver transplant programs in Los Angeles prior to joining the USC program in 2001. Dr Sher has participated in and overseen over 50 research projects and is currently very active in the development of the clinical and basic science research components of the USC Abdominal Organ Transplantation Program. She has numerous publications on immunosuppression, chronic rejection, disease recurrence, infection, and hepatobiliary surgery.

Dr Sher is one of the original editors of Current Opinion in Organ Transplantation and has endeavored over the years to provide the reader with an up to date overview of the entire field of organ transplantation.


Josep M. Grinyó

Josep M. Grinyó

Dr Josep Grinyó, MD, PhD, is Emeritus Professor of Medicine at the University of Barcelona. Dr Grinyó's research work on renal transplantation has been focused on immunosuppression, ischemia-reperfusion injury and chronic allograft damage in the clinical setting and in experimental animal models.

He has held more than 60 competitive research projects and he has authored more than 340 articles and given more than 250 invited lectures.

He has acted as associate editor and reviewer in the top ranked journals in his field of expertise (AJT, CJASN, JASN, NEJM, NDT, TI, Lancet). He has been member of the councils of the scientific societies and chair of several scientific programs committees of congresses of these societies (TTS, ERA-EDTA, ESOT, ISN). He is member of several steering committees and DSMBs of international research consortiums on cell therapy, biomarker-driven immunosuppression, treatment of autoimmune nephritis and organ preservation. He is reviewer of competitive research applications for research organisations in Spain, Belgium, Germany, France (Inserm), Argentine, Austria, USA and UK (MRC, EME Experts).

Jerzy Kupiec-Weglinski

Jerzy Kupiec-Weglinski

Dr Jerzy Kupiec-Weglinski is the Director of Dumont-University of California, Los Angeles (UCLA) Transplant Research Laboratories in Los Angeles, USA. He is Professor of Surgery and Pathology, and Vice-Chairman, Department of Surgery (Research), at the David Geffen School of Medicine at UCLA. He holds the Joan S. and Ralph N. Goldwyn Endowed Chair in Transplantation Research. Dr Kupiec-Weglinski's interests focus on the immunobiology of organ ischemia and reperfusion injury, host sensitization, and tolerance induction in transplant recipients. He has authored over 400 papers. His research for the last 28 years has been funded by National Institute of Health (NIH). He served as standing member of the Transplantation, Tolerance and Tumor Immunology (TTT) NIH Study Section, as member of the board of directors of American Society of Transplantation, and recipient of AST/Astellas Established Investigator Award in Basic Transplant Research. He holds the Honorary Doctorate (“Honoris Causa”) from Medical Academy in Warsaw, and is the Foreign Member of Polish Academy of Sciences.


Didier Mandelbrot

Didier Mandelbrot

Dr Mandelbrot is the Virginia Lee Cook Professor in Transplant Nephrology at the University of Wisconsin School of Medicine and Public Health, and the Medical Director of Kidney and Pancreas Transplantation at UW Health. He was an undergraduate at Harvard College, medical student and medicine resident at the University of Pennsylvania and renal fellow at Brigham and Women's Hospital. He has a longstanding interest in immunosuppressive protocols and transplant complications, and has published over 200 papers. He has a particular interest in living kidney donation. He is a past Chair of the American Society of Transplantation's Living Donor Community of Practice and currently serves as the Chair of the LDCOP Kidney Paired Exchange Workgroup. He is an Associate Editor of Clinical Transplantation.

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.